10 11 dihydroxyaporphine, 10 11 dihydroxyaporphine, 6ar 6 methyl 5 6 6a 7 tetrahydro 4h dibenzo de g quinoline 10 11 diol
For the acute, intermittent treatment of hypomobility, off episodes (end-of-dose wearing off and unpredictable on/off episodes) associated with advanced Parkinson's disease.